Novavax





Ebit Changement Date
Adma Biologics USD 49.19M 7.26M 2025-09
Agenus USD -13.31M 19.08M 2025-03
AstraZeneca USD -1.5B 5.01B 2025-09
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
Cassava Sciences USD -11.86M 33.53M 2025-09
Dynavax Technologies USD 21.27M 10.41M 2025-09
Geron USD -13.89M 1.43M 2025-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
MannKind USD -41.05M 2.36M 2025-09
Merck USD 6.24B 1.32B 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD -260M 557M 2025-09
Novartis USD 4.48B 343M 2025-09
Novavax USD -134.02M 49.55M 2024-09
Pfizer USD 4.65B 71M 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
TG Therapeutics USD 29.36M 5.48M 2025-09


Novavax - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.